Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Giants Stryker And Baxter Embrace A ‘Quality First’ Culture – And Yield Positive Results

Executive Summary

From cutting costs to getting products to market faster, experts at the two companies explain why it pays to keep quality at the fore.

You may also be interested in...



10 Things You Need To Know About FDA’s Proposed Quality Management System Regulation

Longtime industry experts Kim Trautman and Eric Henry highlight some of the more important takeaways from the US FDA’s draft rule that would create a new Quality Management System Regulation, or QMSR, to replace its current Quality System Regulation.

Success Of Case For Quality Program Triggers ‘Culture Shift’ At FDA's Device Center, Officials Say

The US FDA’s Cisco Vicenty and Bleta Vuniqi say the Case for Quality Voluntary Improvement Program has shifted the culture at the agency’s Center for Devices and Radiological Health. That shift is “starting to … feed and percolate into other areas and other activities that the center’s been engaged in,” Vicenty says.

Leadership Engagement Playbook Gives 10 Best Practices To Cultivate Quality Culture

The new playbook from the Case for Quality Collaborative Community aims to shift the mindset of device manufacturers from one of regulatory compliance to one of organization-wide quality.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT144319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel